09.07.2014 • News • Mergers & Acquisitions (M&A) • AkzoNobel • Dede Willams

AkzoNobel Selling Paper Chemicals Business to Kemira

AkzoNobel plans to sell its global paper chemicals business to Finnish chemical producer Kemira for €153 million. The unit that belongs to Pulp and Performance Chemicals business reported sales of €243 million in 2013.

CEO Ton Büchner said the intended sale follows a strategic review of the AkzoNobel portfolio with an eye to focusing on leading positions.

The Pulp Bleaching business, with its Eka trade name, and the Colloidal Silica business are regarded as core and are not up for sale.

Werner Fuhrmann, the Dutch group's Executive Committee member responsible for Specialty Chemicals, said the Pulp and Performance Chemicals business will continue to focus on global leadership positions in pulp bleaching, colloidal silica and expandable microspheres.

Akzo Nobel plans to continue toll manufacture of certain products for Kemira and also will sign a distribution agreement with the buyer for the paper- related part of Colloidal Silica.

The transaction is expected to be completed about six months, subject all clearances.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Top-Feature

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.